Inhibition of CDK4/6 Promotes CD8 T-cell Memory Formation-Reference-Cited by-同舟云学术

Inhibition of CDK4/6 Promotes CD8 T-cell Memory Formation

Published:2021-05-03 Issue:10 Volume:11 Page:2564-2581
ISSN:2159-8274
Container-title:Cancer Discovery
language:en
Short-container-title:Cancer Discov

Author:

Heckler Max,Ali Lestat R.^ORCID,Clancy-Thompson Eleanor,Qiang Li^ORCID,Ventre Katherine S.^ORCID,Lenehan Patrick,Roehle Kevin,Luoma Adrienne,Boelaars Kelly,Peters Vera,McCreary Julia,Boschert Tamara,Wang Eric S.,Suo Shengbao,Marangoni Francesco,Mempel Thorsten R.^ORCID,Long Henry W.^ORCID,Wucherpfennig Kai W.^ORCID,Dougan Michael,Gray Nathanael S.^ORCID,Yuan Guo-Cheng,Goel Shom^ORCID,Tolaney Sara M.,Dougan Stephanie K.

Funder

Ludwig Center at HarvardNIHNIH

NIH

Mentored Clinical Scientist Development Award

NHMRC

Susan G. Komen

NIHHarvard Cancer CentreHarvard Cancer Centre

German Research Foundation

Publisher

American Association for Cancer Research (AACR)

Subject

Oncology

Cited by 77 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mechanisms of sensitivity and resistance to CDK4/CDK6 inhibitors in hormone receptor-positive breast cancer treatment;Drug Resistance Updates;2024-09

2. Prophylaxis with abemaciclib delays tumorigenesis in dMMR mice by altering immune responses and reducing immunosuppressive extracellular vesicle secretion;Translational Oncology;2024-09

3. Fate induction in CD8 CAR T cells through asymmetric cell division;Nature;2024-08-28

4. Identification of CDK4/6 Inhibitors as Small Molecule NLRP3 Inflammasome Activators that Facilitate IL-1β Secretion and T Cell Adjuvanticity;Journal of Medicinal Chemistry;2024-08-20

5. Predictive value of tumor-infiltrating lymphocytes for neoadjuvant therapy response in triple-negative breast cancer: A systematic review and meta-analysis;World Journal of Clinical Oncology;2024-07-24